Item 7.01 Regulation FD Disclosure.
On September 16, 2022, CEN Biotech Inc. (the "Company") issued a press release
(the "Press Release"). The Press Release provides a business update on the
launch of a new product by the Company. The Press Release is furnished hereto as
Exhibit 99.1 and is incorporated by reference herein. The information contained
in the Press Release is being furnished and shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liability of that Section, and shall not be
incorporated by reference into any registration statement or other document
filed under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1** Press Release
dated September
16, 2022.
104 Cover Page
Interactive Data
File (embedded
within the
Inline XBRL
document)
**Furnished herewith.
© Edgar Online, source Glimpses